Peer Review reports
From: Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer
| Original Submission | ||
|---|---|---|
| 14 Jun 2015 | Submitted | Original manuscript |
| Author responded | Author comments | |
| Reviewed | Reviewer Report | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Author responded | Author comments | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Author responded | Author comments | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 3 Nov 2015 | Editorially accepted | |
| 11 Nov 2015 | Article published | 10.1186/s12885-015-1900-y |
You can find further information about peer review here.